Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 1.11.1.21 extracted from

  • Munir, A.; Wilson, M.T.; Hardwick, S.W.; Chirgadze, D.Y.; Worrall, J.A.R.; Blundell, T.L.; Chaplin, A.K.
    Using cryo-EM to understand antimycobacterial resistance in the catalase-peroxidase (KatG) from Mycobacterium tuberculosis (2021), Structure, 29, 899-912.e4 .
    View publication on PubMedView publication on EuropePMC

Crystallization (Commentary)

Crystallization (Comment) Organism
purified wild-type and mutant enzymes with bound isoniazid, X-ray diffraction structure determination and analysis at 2.7-3.7 A resolution, dimeric cryo-electronmicroscopic structure of KatGINH. The two protomers are nearly identical, with a root-meansquare deviation (RMSD) value of 0.4 A for Ca atoms when superposing protomer A onto protomer B. There is one notable difference, with protomer B displaying density for residues 206-221. These residues form part of a large loop insertion (LL1), which extends from Glu195 to Asn231 and includes Tyr229 of the MYW catalytic triad. Density for these residues is not observed in protomer A Mycobacterium tuberculosis

Protein Variants

Protein Variants Comment Organism
T275P site-directed mutagenesis of the residue from the loop close to the heme binding site. The structure of mutant T275P displays significant areas of disorder compared with the wild-type KatG. Several loops surrounding the heme pocket contain little or no density in either protomer A or B. These disordered regions are identical to those in protomer A of the W107R variant. The loop containing the Thr275 residue (residues 274-329) displays no density and therefore cannot be modeled Mycobacterium tuberculosis
W107R site-directed mutagenesis of the catalytic residue, the mutant displays only one heme bound per homodimer of protein. The heme is absent from protomer A and displays significant structural disorder in the vicinity of the heme binding site. Several areas surrounding the heme pocket are difficult to model in protomer A, either displaying minimal or fragmented density. The mutant C-terminal domain of both protomers remains similar to wild-type KatG. The mutant's Arg residue results in disruption of the covalently linked catalytic triad. The loop containing Tyr229, which is part of the MYW catalytic triad is disordered in both protomers, presumably as a consequence of the mutation Mycobacterium tuberculosis

Metals/Ions

Metals/Ions Comment Organism Structure
Fe2+ the heme group Mycobacterium tuberculosis

Molecular Weight [Da]

Molecular Weight [Da] Molecular Weight Maximum [Da] Comment Organism
161000
-
gel filtration Mycobacterium tuberculosis

Natural Substrates/ Products (Substrates)

Natural Substrates Organism Comment (Nat. Sub.) Natural Products Comment (Nat. Pro.) Rev. Reac.
2 H2O2 Mycobacterium tuberculosis
-
O2 + 2 H2O
-
?
2 H2O2 Mycobacterium tuberculosis H37Rv
-
O2 + 2 H2O
-
?
2 H2O2 Mycobacterium tuberculosis ATCC 25618
-
O2 + 2 H2O
-
?
isoniazid + H2O2 Mycobacterium tuberculosis pro-drug activation ?
-
?
isoniazid + H2O2 Mycobacterium tuberculosis H37Rv pro-drug activation ?
-
?
isoniazid + H2O2 Mycobacterium tuberculosis ATCC 25618 pro-drug activation ?
-
?

Organism

Organism UniProt Comment Textmining
Mycobacterium tuberculosis P9WIE5
-
-
Mycobacterium tuberculosis ATCC 25618 P9WIE5
-
-
Mycobacterium tuberculosis H37Rv P9WIE5
-
-

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
2 H2O2
-
Mycobacterium tuberculosis O2 + 2 H2O
-
?
2 H2O2
-
Mycobacterium tuberculosis H37Rv O2 + 2 H2O
-
?
2 H2O2
-
Mycobacterium tuberculosis ATCC 25618 O2 + 2 H2O
-
?
isoniazid + H2O2 pro-drug activation Mycobacterium tuberculosis ?
-
?
isoniazid + H2O2 enzyme binding structure analysis, modeling, overview Mycobacterium tuberculosis ?
-
?
isoniazid + H2O2 pro-drug activation Mycobacterium tuberculosis H37Rv ?
-
?
isoniazid + H2O2 enzyme binding structure analysis, modeling, overview Mycobacterium tuberculosis H37Rv ?
-
?
isoniazid + H2O2 pro-drug activation Mycobacterium tuberculosis ATCC 25618 ?
-
?
isoniazid + H2O2 enzyme binding structure analysis, modeling, overview Mycobacterium tuberculosis ATCC 25618 ?
-
?

Subunits

Subunits Comment Organism
homodimer 2 * 80000, about sequence calculation Mycobacterium tuberculosis

Synonyms

Synonyms Comment Organism
KatG
-
Mycobacterium tuberculosis
Rv1908c
-
Mycobacterium tuberculosis

Temperature Optimum [°C]

Temperature Optimum [°C] Temperature Optimum Maximum [°C] Comment Organism
20
-
assay at Mycobacterium tuberculosis

pH Optimum

pH Optimum Minimum pH Optimum Maximum Comment Organism
7
-
assay at Mycobacterium tuberculosis

Cofactor

Cofactor Comment Organism Structure
heme determination and analysis of the structure of the heme environment of wild-type KatG and KatG bound to isoniazid, overview. The inactivated pro-drug added to the sample is not perturbing the heme site Mycobacterium tuberculosis

General Information

General Information Comment Organism
malfunction mutations that render the enzyme unable to activate the pro-drug lead to isoniazid (INH) resistance. For two INH resistance variants, W107R and T275P, significant structural disorder relating to heme uptake and retention is the likely cause for INH resistance, dynamics of heme binding are determined by cryo-electronmicroscopy of wild-type and mutant enzymes at 2.7-3.7 A resolution, overview Mycobacterium tuberculosis
additional information KatG structure-function analysis, overview Mycobacterium tuberculosis
physiological function KatG from Mycobacterium tuberculosis is a catalase-peroxidase that can utilize and degrade hydrogen peroxide (H2O2) either through functioning as a catalase or as a peroxidase. In Mycobacterium tuberculosis, the multifunctional heme enzyme KatG is indispensable for activation of isoniazid (INH), a first-line pro-drug for treatment of tuberculosis. The activated drug species forms an INH-NAD adduct that subsequently triggers anti-tubercular activity Mycobacterium tuberculosis